Showing results (251-260 of 532) with videos related to

Sort By:
Pageof 54
Circulation. Genomic and Precision Medicine|June 28, 2024
Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate PotentialJ Brett Heimlich, Michael A Raddatz, John Wells, et al.
Research Square|October 4, 2023
Detection of distant relatedness in biobanks for identification of undiagnosed carriers of a Mendelian disease variant: application to Long QT SyndromeMegan C Lancaster, Hung-Hsin Chen, M Benjamin Shoemaker, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
Journal of the American College of Cardiology|September 28, 2019
Cardiovascular Toxicities Associated With IbrutinibJoe-Elie Salem, Ali Manouchehri, Marie Bretagne, et al.
American Journal of Human Genetics|June 14, 2020
High-Throughput Reclassification of SCN5A VariantsAndrew M Glazer, Yuko Wada, Bian Li, et al.
Pharmacotherapy|July 9, 2017
Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT)Jason H Karnes, Christian M Shaffer, Robert Cronin, et al.
Disease Models & Mechanisms|December 11, 2012
Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythmIris I Müller, David B Melville, Vineeta Tanwar, et al.
Circulation|January 24, 2007
Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytesPeter J Mohler, Solena Le Scouarnec, Isabelle Denjoy, et al.
Circulation|October 3, 2014
Temporal trends in coverage of historical cardiac arrests using a volunteer-based network of automated external defibrillators accessible to laypersons and emergency dispatch centersCarolina Malta Hansen, Freddy Knudsen Lippert, Mads Wissenberg, et al.
Trials|August 29, 2021
2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable deviceMatthew J O'Neill, Zachary T Yoneda, Diane M Crawford, et al.
Pageof 54